期刊文献+

过表达PKM2增加卵巢癌细胞的增殖和迁移 被引量:4

Up-regulation of Pyruvate Kinase Type M2 Contributes to Elevated Ovarian Cancer Cell Proliferation and Migration
原文传递
导出
摘要 目的探究人M2型丙酮酸激酶(pyruvatekinasetypeM2,PKM2)对卵巢癌SKOV3细胞增殖和迁移的影响。方法将PKM2cDNA以XhoI和NotI位点克隆入pLVX—Neo—IRES.ZsGreenlvector慢病毒载体中,得到的重组载体及空载体分别与慢病毒包装质粒psPAX2和pMD2.G共转染入293T包装细胞.以得到PKM2过表达的慢病毒表达载体;将其转导入SKOV3细胞后用G418筛选稳定转染的细胞,分别测定PKM2过表达前后SKOV3细胞的增殖和迁移的改变。结果测序鉴定表明PKM2重组慢病毒表达载体正确无误。Western印迹检测结果显示转导PKM2慢病毒表达载体可增加SKOV3细胞中PKM2的表达。MTT测定和细胞划痕实验结果表明过表达PKM2可增加SKOV3的增殖和迁移。结论PKM2过表达可增加卵巢癌SKOV3细胞的增殖和迁移。 Objective To construct human pyruvate kinase type M2 (PKM2) gene recombi- nant lentivirus expression vector and to investigate its effect on the ovarian cancer SKOV3 cell prolif- eration and migration. Methods XhoI and NotI restriction enzyme sites were introduced into 5' and 3' end of PKM2 cDNA, respectively by PCR amplification. PKM2 eDNA was inserted into pLVX-Neo-IRES-Zs Greenl lentivirus vector via these two enzyme sites. The recombinant ptasmid and empty plasmid were cotransfected with psPAX2 and pMD2. G packaging plasimds into 293T cells to form PKM2 over-expressing lentivirus vector, which were then used to transduce SKOV3 cells. C,418 was used to select the cell clones with stable PKM2 over-expression or empty vector, re- spectively. MT-F and cell wound healing assays were used to detect SKOV3 cell proliferation and mi- gration. Results Sequencing demonstrated that PKM2 recombinant lentivirus expressing vector was successfully constructed and Western blotting exhibited that transduced PKM2 over-expressing lentivirus vector was able to increase the expression of PKM2 in SKOV3 cells. MTT and cell wound healing assays showed that over-expressed PKM2 resulted in elevated SKOV3 cell proliferation and migration. Conclusion s The PKM2 gene recombinant lentivirus expressing vector was successfully constructed, and up-regulated PKM2 expression contributed to increased proliferation and migration in SKOV3 cells.
出处 《医学分子生物学杂志》 CAS 2018年第1期1-7,共7页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.81372788)
关键词 PKM2慢病毒过表达载体 SKOV3卵巢癌细胞 MTY实验 细胞划痕实验 PKM2 lentivirus expression vector SKOV3 ovarian cancer cells MT1~ assay cell wound healing assay
  • 相关文献

参考文献1

二级参考文献20

  • 1Maeda T, Inoue M, Koshiba S, et al. Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125(MUC16) [J]. J Biol Chem, 2004, 279( 13): 13174-13182.
  • 2Benjapibal M, Neungton C. Pre-operative prediction of serumCA125 level in women with ovarian masses [J]. J Med Assoc Thai, 2007, 90( 10): 1986-1991.
  • 3Menon U, Skates SJ, Lewis S, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer [J]. J Clin Oncol, 2005, 23 (31 ): 7919-7926.
  • 4Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass [J ]. Gynecol Oncol, 2008, 108 (2):402-408.
  • 5Zhang Z, Yu Y, Xu F, et al. Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer [J ]. Gynecol Oncol, 2007, 107(3): 526-531.
  • 6Visintin I, Feng Z, Longton G, et al. Diagnostic markers for early detection of ovarian cancer [J]. Clin Cancer Res, 2008, 14 (4): 1065-1072.
  • 7Bertenshaw GP, Yip P, Seshaiah P, et al. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer [J]. Cancer Epidemiol Biomarkers Prey, 2008, 17(10): 2872-2881.
  • 8Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas [J]. Cancer Res, 2005, 65 (6): 2162-2169.
  • 9Ho M, Hassan R, Zhang J, et al. Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients [J]. Clin Cancer Res, 2005, 11 ( 10): 3814-3820.
  • 10Hassan R, Remaley AT, Sampson ML, et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer[J]. Clin Cancer Res, 2006, 12(2): 447-453.

共引文献45

同被引文献42

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部